Theodoros Kyriakides

Medicine & Life Sciences

1. Cyprus 100%
2. Mitochondrial Encephalomyopathies 67%
3. Vestibular Evoked Myogenic Potentials 64%
4. Muscles 60%
5. Spinal Muscular Atrophy 57%
6. Mutation 51%
7. Prealbumin 51%
8. Muscular Diseases 47%
9. Electron Microscopy 40%
10. Multiple Sclerosis 39%
11. Myasthenia Gravis 36%
12. Amyloid 36%
13. Age of Onset 33%
14. Genes 32%
15. Biopsy 32%
16. Charcot-Marie-Tooth Disease 32%
17. Neuronopathy, Distal Hereditary Motor, Type V 31%
18. Phenotype 29%
19. Myalgia 27%
20. Polyneuropathies 27%
21. Duchenne Muscular Dystrophy 27%
22. Transgenic Mice 25%
23. Amyotrophic lateral sclerosis 1 25%
24. Chromosomes 23%
25. Glycine-tRNA Ligase 23%
26. Muscle Form Glycogen Phosphorylase 23%
27. Plasma Exchange 22%
28. Muscular Dystrophies 22%
29. Amyloid Neuropathies 21%
30. Dystrophin-Associated Proteins 21%
31. Population 21%
32. Refsum Disease 21%
33. Phytanic Acid 20%
34. Glycogen Storage Disease Type V 20%
35. Familial Amyloid Neuropathies 19%
36. Amyloidosis, Hereditary, Transthyretin-Related 19%
37. Sarcoglycans 19%
38. Dystrophin 19%
39. Amyotrophic Lateral Sclerosis 19%
40. Penetrance 18%
41. Spinal Muscular Atrophies of Childhood 18%
42. Angelman Syndrome 18%
43. Lipoprotein Receptors 17%
44. Dystonic Disorders 17%
45. Creatine Kinase 17%
46. Antibodies 16%
47. Chromosomes, Human, Pair 13 16%
48. Hypoventilation 16%
49. Restless Legs Syndrome 16%
50. Sarcolemma 16%